Radiofrequency Ablation of Drug‐Resistant Cancer Cells Using Molecularly Targeted Carboxyl‐Functionalized Biodegradable Graphene | Zendy

Sasidharan Abhilash | Zendy; Sivaram Amal J. | Zendy; Retnakumari Archana P. | Zendy; Chandran Parwathy | Zendy; Malarvizhi Giridharan Loghanathan | Zendy; Nair Shantikumar | Zendy; Koyakutty Manzoor | Zendy

Premium

Radiofrequency Ablation of Drug‐Resistant Cancer Cells Using Molecularly Targeted Carboxyl‐Functionalized Biodegradable Graphene

Author(s) -

Sasidharan Abhilash,

Sivaram Amal J.,

Retnakumari Archana P.,

Chandran Parwathy,

Malarvizhi Giridharan Loghanathan,

Nair Shantikumar,

Koyakutty Manzoor

Publication year - 2015

Publication title -

advanced healthcare materials

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.288

H-Index - 90

eISSN - 2192-2659

pISSN - 2192-2640

DOI - 10.1002/adhm.201400670

Subject(s) - graphene , materials science , nanotechnology , conjugated system , drug delivery , targeted drug delivery , drug , nanoparticle , radiofrequency ablation , computer science , ablation , cancer research , medicine , pharmacology , polymer , composite material

Under ultralow radiofrequency (RF) power , transferrin‐conjugated graphene nanoparticles can thermally ablate drug‐ or radiation‐resistant cancer cells very effectively. The results suggest that graphene‐based RF hyperthermia can be an efficient method to manage drug‐/radiation‐resistant cancers.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research